Global X S&P Biotech ETF (ASX:CURE)
Australia
· Delayed Price · Currency is AUD 43.97
+0.05 (0.11%)
Jul 9, 2025, 4:10 PM AEST
ASX:CURE Holdings Information
ASX:CURE is an equity ETF with a total of 10 individual holdings. The top holdings are Alnylam Pharmaceuticals stock at 2.61%, Insmed at 2.59%, Exelixis at 2.55%, United Therapeutics at 2.51%, and Neurocrine Biosciences at 2.49%.
Total Holdings
10
Top 10 Percentage
24.68%
Asset Class
Equity
ETF Category
Health Care
Assets
30.15M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
As of Jun 26, 2025
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.61% |
| 2 | INSM | Insmed Incorporated | 2.59% |
| 3 | EXEL | Exelixis, Inc. | 2.55% |
| 4 | UTHR | United Therapeutics Corporation | 2.51% |
| 5 | NBIX | Neurocrine Biosciences, Inc. | 2.49% |
| 6 | REGN | Regeneron Pharmaceuticals, Inc. | 2.43% |
| 7 | VRTX | Vertex Pharmaceuticals Incorporated | 2.39% |
| 8 | NTRA | Natera, Inc. | 2.38% |
| 9 | INCY | Incyte Corporation | 2.38% |
| 10 | HALO | Halozyme Therapeutics, Inc. | 2.35% |
As of Jun 26, 2025